https://thevitalrecord.ai/2026/06/12/belzutifan-pembro-adjuvant-rcca-approval/ The Vital Record en 2026-06-12T00:00:00.000Z FDA Approves Belzutifan Plus Pembrolizumab as First Adjuvant Combination Therapy for High-Risk Clear-Cell Renal Cell Carcinoma https://thevitalrecord.ai/2026/06/12/lassa-fever-vaccine-phase1-lassarab/ The Vital Record en 2026-06-12T00:00:00.000Z First-in-Human Lassa Fever Vaccine Reports 100% Seroconversion in Phase 1 Trial https://thevitalrecord.ai/2026/06/12/dmg-brain-network-survival-nature/ The Vital Record en 2026-06-12T00:00:00.000Z Fatal Paediatric Brain Tumours Are Wired Into the Brain — Disrupting That Network May Extend Survival https://thevitalrecord.ai/2026/06/12/artemisinin-resistance-zambia-southwest-africa/ The Vital Record en 2026-06-12T00:00:00.000Z Preliminary Data: Artemisinin-Resistance Mutation Has Swept to 79% in Western Zambia, With Day-3 Positivity 28 Times Higher Than Eastern Zambia https://thevitalrecord.ai/2026/06/12/integrate-iib-regonivo-gej-cancer-phase3/ The Vital Record en 2026-06-12T00:00:00.000Z RegoNivo Fails to Extend Survival in Phase 3 Gastric Cancer Trial, Deflating Early-Phase Enthusiasm https://thevitalrecord.ai/2026/06/12/us-measles-2073-cases-elimination-risk/ The Vital Record en 2026-06-12T00:00:00.000Z U.S. Measles Cases Reach 2,073 Across 40 Jurisdictions — Elimination Status at Risk Before November Review https://thevitalrecord.ai/2026/06/12/jnj-firefly-bio-kras-degrader-acquisition/ The Vital Record en 2026-06-12T00:00:00.000Z J&J to Acquire Firefly Bio for $1 Billion, Gaining Nobel Laureate-Backed KRAS-Targeting Degrader Antibody Conjugate Platform https://thevitalrecord.ai/2026/06/12/cytisinicline-pdufa-june20-smoking-cessation/ The Vital Record en 2026-06-12T00:00:00.000Z FDA Decision Due June 20 on Cytisinicline — First New Smoking-Cessation Drug Since Varenicline in 2006